Form 4: Pliant Therapeutics CFO Exercises Stock Options and Acquires Shares

Keith Lamont Cummings, CFO of Pliant Therapeutics, exercised stock options and acquired 21,000 shares of common stock at $2.08 per share on May 2, 2024.

Summary

• On May 2, 2024, Keith Lamont Cummings, the Chief Financial Officer of Pliant Therapeutics, exercised stock options to acquire 21,000 shares of common stock at a price of $2.08 per share.
• Following this transaction, Cummings directly owns 271,713 shares of Pliant Therapeutics common stock.
• The exercised stock options were granted previously, with 25% vesting on December 31, 2019, and the remainder vesting monthly thereafter, contingent upon continuous service.
• Cummings also acquired 858 shares of common stock through an Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but the CFO exercising options could be seen as a mildly positive signal.

Positives

• The CFO's decision to exercise stock options and increase his holdings could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.

Comparison to Industry Standards

• Insider transactions are common in publicly traded companies, and the exercise of stock options is a typical form of compensation for executives.
• The vesting schedule of the options is also standard, aligning with industry practices for incentivizing long-term commitment from employees.
• Comparing the size of Cummings' holdings to those of executives at similar biotech companies (e.g., executives at companies like FibroGen or Galapagos) could provide further context.

Stakeholder Impact

• The transaction has a minor impact on shareholders by slightly increasing the number of outstanding shares.

Key Dates